Drug class
Interleukin-4 Receptor alpha Antagonist; Antibodies, Monoclonal
Mechanism of action
Interleukin 4 Receptor alpha Antagonists [MoA]
General use cases
- Dermatitis, Atopic
- adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable
- acute bronchospasm or status asthmaticus
- adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE)
- adult patients with prurigo nodularis (PN)
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
